Because changing endpoints is not always a panacea. The FDA agreed to let RLFTF change their primary endpoint. Everybody was happy about that !!! But then after all of that fuss and excitement, they failed to meet the new, shiny primary endpoint. It's a Hail Mary. Yes, sometimes it can work. Maybe it will here with RVVTF. I'm not bearish or bullish here, because it's like a crapshoot. I can't predict the FDA's behavior either.
News 
Market Data 
Discover 
AI
